Pfizer Inc. (BCBA:PFE)

Market Cap	208.74T
Revenue (ttm)	75.80T
Net Income (ttm)	12.77T
Shares Out	n/a
EPS (ttm)	2,248.99
PE Ratio	16.35
Forward PE	9.34
Dividend	307.41 (3.09%)
Ex-Dividend Date	Jul 25, 2025

Volume	25,162
Average Volume	48,983
Open	10,270.00
Previous Close	10,250.00
Day's Range	9,895.00 - 10,380.00
52-Week Range	5,990.00 - 10,800.00
Beta	0.47
RSI	59.48
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD